RA: No significant change in efficacy and safety after adalimumab to CT-P17 switchJuly 27, 2021Rheumatoid Arthritis
Rheumatology NewsCOVID-19 vaccine hesitancy still weighs heavy for some rheumatic disease patientsJuly 21, 2021COVID-19 UpdatesRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitisLupus & Connective Tissue Diseases
Rheumatology NewsVertebral fractures still a risk with low-dose oral glucocorticoids for RAJuly 20, 2021Rheumatoid ArthritisOsteoporosis
Clusterin could serve as a potential predictive biomarker for disease activity and treatment response in early RAJune 24, 2021Rheumatoid Arthritis
HR-pQCT scanning has comparable diagnostic precision to conventional radiography for classifying erosive RAJune 24, 2021Rheumatoid Arthritis
Early glucocorticoids bridging reduces chronic NSAID and analgesic use in early RA patients with a favorable prognosisJune 24, 2021Rheumatoid Arthritis
Tocilizumab raises risk of diverticulitis and GI perforation vs. rituximab and abatacept in RAJune 24, 2021Rheumatoid Arthritis
Worse COVID-19 outcomes in RA patients treated with rituximab and JAKiJune 24, 2021Rheumatoid Arthritis
RA: Tofacitinib modified-release 11 mg OD plus methotrexate shows promise in ORAL Shift trialJune 24, 2021Rheumatoid Arthritis
